Jean-Luc Canon

2.0k citations
35 papers · 1.1k indexed · h-index 16
Topics
Cancer Treatment and Pharmacology (7 papers)HER2/EGFR in Cancer Research (7 papers)Lung Cancer Treatments and Mutations (7 papers)

In The Last Decade

Jean-Luc Canon

35 papers receiving 1.0k citations

Peers

Jean-Luc Canon
Comparison fields: 5 of 76
  • Oncology 740
  • Cancer Research 473
  • Pulmonary and Respiratory Medicine 216
  • Molecular Biology 209
  • Genetics 97
Replace Chantal Bernard-Marty with:
Chantal Bernard-Marty Belgium
Antonio Febbraro Italy
Vincenzo Sforza Italy
Andrea Michelotti Italy
Samuele Massarut Italy
Adrian Langleben Canada
Lola Anagnostaki Sweden
In Ae Park South Korea
N.J. Bundred United Kingdom
Konstantinos Venetis Italy
Jean-Luc Canon relative to Chantal Bernard-Marty Belgium Chantal Bernard-Marty's profile →
Citations per field
00.5×4.2×
Chantal Bernard-Marty · 1×
Citations per year

Countries citing papers authored by Jean-Luc Canon

Since Specialization
Citations

This map shows the geographic impact of Jean-Luc Canon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Luc Canon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Luc Canon more than expected).

Fields of papers citing papers by Jean-Luc Canon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Luc Canon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Luc Canon. The network helps show where Jean-Luc Canon may publish in the future.

Co-authorship network of co-authors of Jean-Luc Canon

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Luc Canon. A scholar is included among the top collaborators of Jean-Luc Canon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Luc Canon. Jean-Luc Canon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 15
4 26
5 76
6 47
7 19
8 1
9 16
10 19
11 30
12 1
13 48
14 128
15 6
16 27
17
First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicentre academic phase II study in caucasian patients (pts) (NCT00339586)
1
18
Treatment effect of panitumumab in subsets by epidermal growth factor receptor (EGFR) status from a phase 3 randomized controlled trial
2
19 401
20 8

About Jean-Luc Canon

Jean-Luc Canon is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Cancer Research (473 citations), Oncology (740 citations) and Pulmonary and Respiratory Medicine (216 citations). Jean-Luc Canon has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Mario Campone, Anne‐Laure Martin, Henri Roché, M. Spielmann, Pierre Kerbrat, Jean-­Marc Ferrero, Bernard Asselain, Daniel Serin, Michel Symann and P Soulié. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026